Status:
COMPLETED
Distraction Osteogenesis in Limb-length Discrepancy With Mesenchymal Cell Transplantation
Lead Sponsor:
Royan Institute
Conditions:
Leg Length Inequality
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Limb-length discrepancy can be due to many causes. These are divided into three groups: congenital (from birth), developmental (from a childhood disease or injury that slows or damages the growth plat...
Detailed Description
Distraction osteogenesis has been widely utilized to treat leg length discrepancy, deformity, nonunion, osteomyelitis, and bone loss. It has been found that most difficult conditions can be resolved w...
Eligibility Criteria
Inclusion
- both gender
- patient with limb-length discrepancy
- Age:18-65
Exclusion
- Diagnosis of cancer,DM,CNS disorder,thyroid disease or respiratory disease
- Known allergic reaction to components of study treatment and/or study injection procedure
- Patients infected with hepatitis B,C or HIV
- pregnancy
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01210950
Start Date
September 1 2009
End Date
December 1 2013
Last Update
April 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Iran